Busilong Pharmaceuticals: Change in Drug Production License of Wholly-owned Subsidiary

Bu Xing Pharmaceutical announced that its wholly-owned subsidiaries Bu Xing High-Tech and Shaanxi Bu Xing Pharmaceutical have obtained approval from the Shaanxi Provincial Drug Administration, with Bu Xing High-Tech expanding its production scope in "capsule formulations" and Shaanxi Bu Xing Pharmaceutical reducing its entrusted production scope for Kechuan An oral liquid. This change involves expanding production scope, changing workshops and production lines, which is beneficial for optimizing production structure, maintaining stable production capacity, and having a positive impact on future operations. However, the long research and development cycle and uncertainties in the pharmaceutical sector should remind investors to pay attention to risks.